According to CytoMed Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.14. In 2021 the company made an earnings per share (EPS) of -$0.14 a decrease over its 2020 EPS that were of -$0.13.
Year | EPS | Change |
---|---|---|
2021 | -$0.14 | 3.73% |
2020 | -$0.13 |